Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001104659-25-079472
Filing Date
2025-08-18
Accepted
2025-08-18 07:30:25
Documents
10

Document Format Files

Seq Description Document Type Size
1 DEFM14A tm2522174-2_defm14a.htm DEFM14A 2768936
2 GRAPHIC lg_veronapharmareg-4c.jpg GRAPHIC 12207
3 GRAPHIC lg_mackenzie-bw.jpg GRAPHIC 12511
4 GRAPHIC lg_veronapharma-4c.jpg GRAPHIC 12599
5 GRAPHIC lg_centerviewpart-bw.jpg GRAPHIC 16580
6 GRAPHIC ft_center-bw.jpg GRAPHIC 16805
7 GRAPHIC px_25veronapx1pg01-4c.jpg GRAPHIC 689294
8 GRAPHIC px_25veronapx1pg02-4c.jpg GRAPHIC 297567
9 GRAPHIC px_25veronapx2pg01-4c.jpg GRAPHIC 613025
10 GRAPHIC px_25veronapx2pg02-4c.jpg GRAPHIC 251183
  Complete submission text file 0001104659-25-079472.txt   5357294
Mailing Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE
Business Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE 011-44-0-2032834200
Verona Pharma plc (Filer) CIK: 0001657312 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 001-38067 | Film No.: 251226276
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)